14121-97-2

Basic information

• Product Name: Benzamide, 4-hydroxy-N-phenyl-
• CAS NO: 14121-97-2
• Molecular Formula: C13H11NO2
• Molecular Weight: 213.236
• Mol File: 14121-97-2.mol
• Article Data: 32

Chemical Properties

• CAS DataBase Reference: Benzamide, 4-hydroxy-N-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, 4-hydroxy-N-phenyl-(14121-97-2)
• EPA Substance Registry System: Benzamide, 4-hydroxy-N-phenyl-(14121-97-2)

Safety Data

• Hazardous Substances Data: 14121-97-2(Hazardous Substances Data)

Upstream product

• 142-04-1 aniline hydrochloride 
• 100-09-4 4-methoxybenzoic acid 
• 62-53-3 aniline 
• 99-96-7 4-hydroxy-benzoic acid 
• 81323-46-8 4-(Hydrazono-phenyl-methyl)-phenol 
• 103-72-0 phenyl isothiocyanate 
• 103-71-9 phenyl isocyanate 
• 288-32-4 1H-imidazole 
• 79-37-8 oxalyl dichloride 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 501-97-3 4-hydroxyphenylpropionic acid 
• 201230-82-2 carbon monoxide 
• 540-38-5 p-Iodophenol 
• 591-50-4 iodobenzene 

Downstream Products

• 90446-66-5 2,6-bis(1-pyrrolidinylmethyl)-4-benzamidophenol 
• 124-38-9 carbon dioxide 
• 62-53-3 aniline 
• 108-95-2 phenol 

Relevant articles and documents

Visible-light-induced direct construction of amide bond from carboxylic acids with amines in aqueous solution

A novel visible-light-promoted N-acylation for the synthesis of amides from easily available carboxylic acids with amines in the presence of I2 within 2.5 h in aqueous solution has been developed. Using sunlight as the visible light source greatly reduces the cost of experiments and produces almost no toxic effects. Hence, this study provides an alternative catalytic system for the construction of a wide range of amides with readily available materials. Moreover, the strategy was successfully applied in the preparation of N-(3-(2,6-dimethoxyphenoxy)-7-nitroquinoxalin-2-yl)benzohydrazide, which displayed a signification anti-proliferation effect on A549, MCF-7 and HCT116 cell lines.

Aryl alkyl ether compound as well as derivative, preparation method, pharmaceutical composition and application thereof

The invention discloses an aryl alkyl ether compound as well as a derivative, a preparation method, a pharmaceutical composition and application thereof. The structure of the aryl alkyl ether compound is shown as a formula (I). The aryl alkyl ether compound derivative relates to a stereoisomer, a tautomer, a metabolite, a metabolic precursor, a prodrug, a solvate, a salt of the solvate, a crystal, a pharmaceutically acceptable salt or a mixture of the stereoisomer, the tautomer, the metabolite, the metabolic precursor, the prodrug and the solvate of the aryl alkyl ether compound. The aryl alkyl ether compound and the derivative thereof have a remarkable inhibition effect on indoleamine 2, 3-dioxygenase 1, and can be used for preparing a medicine for treating indoleamine 2, 3-dioxygenase 1 mediated immunosuppression related diseases, and the prepared medicine can exert the medicine effect at the molecular level and is wide in application.

Synthesis and characterization of Pd(II)–vitamin B6 complex supported on magnetic nanoparticle as an efficient and recyclable catalyst system for C–N cross coupling of amides in deep eutectic solvents

Vitamin B6–Pd(II) immobilized onto magnetic nanoparticles have been successfully prepared and applied for C–Xcross-coupling reactions with aryl halides in green deep eutectic solvents. The results prove that the Fe3O4@vitamin B6–Pd(II) magnetic nanoparticles show high catalyst activity and good stability. It was also revealed that this complex can be recycled up to five times without any significant loss in catalytic activity.